AI Science Tracker

Moorfields Eye Hospital

2 discoveries from 2020 to 2023

Discoveries

RETFound: a foundation model for disease detection from retinal images

RETFound is self-pretrained on unlabelled retinal images, reportedly about 1.6 million from Moorfields Eye Hospital, and then adapted to disease tasks. The authors report better diagnosis of sight-threatening eye diseases than comparison models, better prediction of systemic conditions such as heart failure and myocardial infarction, and strong performance with fewer labels. The evaluation is retrospective, with no clinical deployment study, and the model was released openly.

Technology: RETFound (masked-autoencoder foundation model for retinal images)

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

Result, AI contribution and limits

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

  • Publication status: Peer-reviewed paper
  • Test type: retrospective or benchmark
  • Tested: RETFound, self-pretrained on unlabelled retinal images, was adapted to disease tasks and compared with other models on diagnosis of sight-threatening eye diseases and on prediction of heart failure and myocardial infarction.
  • Still unknown: The abstract states no limitations of this work; the evaluation is retrospective with no clinical deployment study.
  • AI role: A self-supervised foundation model pretrained on retinal images and fine-tuned for disease tasks.

Evidence sources: https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=DOI:10.1038/s41586-023-06555-x&resultType=core&format=json

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review scope and date are not recorded; source checked does not establish full-text review.

Citations: in the top 1% of works of the same type, year and subfield (OpenAlex work metrics, 1177 citations; as of 15 Nov 2026). Attention, not a measure of correctness; not part of the score.

Editorial assessment: Impact 4/5 · Validation 2/5 · Novelty 4/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Follow-up and relationships

No follow-up recorded; this is not a claim that no follow-up exists.

Follow-up review scope and date are not recorded.

No source-supported relationships recorded.

An AI system predicts progression of macular degeneration

The system analyzes OCT scans to predict whether the less affected eye of patients with macular degeneration will develop the wet form, outperforming specialists in the comparison described. The announcement gives no numerical metrics; preventive clinical studies were still to be planned.

Technology: Deep learning on OCT images

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

Result, AI contribution and limits

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

  • Publication status: Peer-reviewed paper
  • Test type: retrospective or benchmark
  • Tested: Retrospective prediction of whether the second eye converts to wet AMD within 6 months: 80% sensitivity at 55% specificity, and better than five of six experts in the comparison described.
  • Still unknown: Preventive use needs prospective trials that were only being considered; 56% of individual eyes were false positives at the high-sensitivity setting; dataset size and generalizability not stated.
  • AI role: Models built on 3D OCT scans and automatically generated tissue maps to predict conversion to wet AMD.

Evidence sources: https://www.moorfields.nhs.uk/about-us/news-and-blogs/news/ai-to-develop-an-early-warning-system-for-amd · https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=DOI:10.1038/s41591-020-0867-7&resultType=core&format=json

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: press release. Paper: linked separately.

Review scope and date are not recorded; source checked does not establish full-text review.

Citations: in the top 1% of works of the same type, year and subfield (OpenAlex work metrics, 307 citations; as of 15 Nov 2026). Attention, not a measure of correctness; not part of the score.

Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Follow-up and relationships

No follow-up recorded; this is not a claim that no follow-up exists.

Follow-up review scope and date are not recorded.

No source-supported relationships recorded.

Open the interactive profile for the timeline, or browse all organizations and model families.